Hypoglycemic Agents

Hypoglycemic agents are medications used to lower blood glucose levels in people with diabetes or other conditions that cause high blood sugar.

Types of Hypoglycemic Agents

  • Sulfonylureas: Stimulate the pancreas to release more insulin, such as glipizide (Glucotrol) and glyburide (DiaBeta).
  • Biguanides: Decrease glucose production in the liver and increase insulin sensitivity, such as metformin (Glucophage).
  • Alpha-glucosidase inhibitors: Delay carbohydrate absorption in the gut, such as acarbose (Precose) and miglitol (Glyset).
  • Thiazolidinediones: Increase insulin sensitivity, such as pioglitazone (Actos) and rosiglitazone (Avandia).
  • DPP-4 inhibitors: Increase insulin release and decrease glucose production in the liver, such as sitagliptin (Januvia) and saxagliptin (Onglyza).
  • GLP-1 receptor agonists: Stimulate insulin release and decrease glucose production in the liver, such as exenatide (Byetta) and liraglutide (Victoza).
  • SGLT2 inhibitors: Decrease glucose reabsorption in the kidneys, such as canagliflozin (Invokana) and empagliflozin (Jardiance).

Indications

Hypoglycemic agents are used to treat:

  • Type 1 diabetes
  • Type 2 diabetes
  • Predabetes
  • Polycystic ovary syndrome (PCOS)
  • Insulin resistance

Administration and Dosage

The administration and dosage of hypoglycemic agents vary depending on the specific medication, patient's condition, and response to treatment.

  • Oral medications: Taken by mouth, usually once or twice a day.
  • Injectable medications: Administered via injection, usually once or twice a day.

Side Effects and Interactions

Hypoglycemic agents can cause side effects, such as:

  • Hypoglycemia (low blood sugar)
  • Nausea and vomiting
  • Diarrhea
  • Headache
  • Dizziness

Interactions with other medications, such as:

  • Beta-blockers
  • Warfarin
  • Aspirin

Monitoring and Follow-up

Regular monitoring of blood glucose levels, kidney function, and liver function is necessary to adjust the dosage and prevent side effects.

  • Fasting plasma glucose (FPG) tests
  • Postprandial glucose (PPG) tests
  • Hemoglobin A1c (HbA1c) tests

Patient Education

Patient education on proper use, dosage, and potential side effects of hypoglycemic agents is essential to ensure safe and effective treatment.

Article last updated on: 15th June 2025.
If you have any feedback, please get in touch.

Diagnosis Pad
Medical AI Assistant with Differentials, Guidance, Transcriptions, Notes, Medical Encyclopedia and Explainable AI.


Available for iOS, macOS and Android.

Medical Disclaimer

The information provided is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this site. We we do not guarantee, and assume no legal liability or responsibility for the accuracy, currency, or completeness of the information provided.